Drugs / ZE74-0282-0001
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07527221 | Apr → Nov 2026 expected | — | Eilean Therapeutics AU Pty Ltd | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ZE74-0282-0001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07527221 ↗ |
| Route | Oral | “ZE74-0282 administered orally in healthy volunteers.” NCT07527221 ↗ |